PNTG
Pennant Group, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$39.62
−1.02%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.33
- Revenue estimate
- $299.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.36
- EPS estimate
- $0.33
- Revenue actual
- $298.0M
- Revenue estimate
- $288.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +6.2%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $46
- PT range
- $44 – $48
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.33 | $0.36 | Beat 8.56% | $298.0M |
| May 7, 2026 | $0.31 | $0.32 | Beat 3.23% | $285.4M |
| Feb 26, 2026 | $0.31 | $0.34 | Beat 9.68% | $289.3M |
| Nov 5, 2025 | $0.29 | $0.30 | Beat 3.45% | $229.0M |
| Aug 6, 2025 | $0.26 | $0.27 | Beat 3.85% | $219.5M |
| Feb 27, 2025 | $0.24 | $0.24 | In line | $188.9M |
| Feb 28, 2024 | $0.22 | $0.22 | In line | $146.0M |
| May 4, 2023 | $0.15 | $0.13 | Miss -13.33% | $126.5M |
| Feb 23, 2023 | $0.18 | $0.18 | In line | $124.7M |
| Feb 28, 2022 | $0.15 | $0.07 | Miss -53.33% | $111.8M |
| May 6, 2021 | $0.18 | $0.11 | Miss -38.89% | $105.7M |
| Feb 24, 2021 | $0.20 | $0.17 | Miss -15.00% | $108.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026